2023 Form 5500 filing — Morton Grove Pharmaceutical, Inc. 401(K) Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20250411151412NAL0012725907001) for Morton Grove Pharmaceutical, Inc. 401(K) Plan, reported by Morton Grove Pharmaceutical, Inc under EIN 36-4049160 and plan number 001. It reports 210 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

EFAST2 acknowledgement
20250411151412NAL0012725907001
Filing year
2023
Form type
2
Plan sponsor
Morton Grove Pharmaceutical, Inc
EIN
36-4049160
Plan number
001
Location
Morton Grove, IL
Participants
210
Schedules available
Schedule H, Schedule C
Received date
not reported in the loaded dataset

Reported financial snapshot (2023)

Total assets (EOY)
$12,004,227
Total liabilities (EOY)
$55,868
Net assets (EOY)
$11,948,359
Employer contributions
$67,415
Participant contributions
$147,635
Total income / additions
$2,061,197
Benefits paid
$2,303,297
Administrative expenses
$12,569
Total expenses
$2,359,543
Net increase / (decrease)
-$298,346
Schedule source
Schedule H

Reported service provider compensation (Schedule C)

Compensation reported on the 2023 filing
ProviderServiceDirect comp.Indirect comp.
Adp, Inc.RECORD KEEPER$7,275$0
Merrill Lynch Pierce Fenner & SmithINVESTMENT ADVISOR$5,293$837
Adp Broker-DealerRECORD KEEPER$0$0

Related Form 5500 pages